Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 4:36 pm Purchase | 2025-08-08 | 13G | Kiora Pharmaceuticals, Inc. KPRX | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 189,705 5.299% | 189,705 (New Position) | Filing History |
| 2025-05-15 4:43 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 502,500 1.900% | 201,000 (+66.67%) | Filing History |
| 2025-05-15 4:42 pm Sale | 2025-03-31 | 13G | Surrozen, Inc. SRZN | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 73,918 2.200% | -103,052 (-58.23%) | Filing History |
| 2025-03-06 4:31 pm Purchase | 2025-02-27 | 13G | DarioHealth Corp. DRIO | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 125,556 5.777% | 125,556 (New Position) | Filing History |
| 2025-02-19 4:32 pm Purchase | 2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 810,630 6.241% | 810,630 (New Position) | Filing History |
| 2025-02-14 4:31 pm Purchase | 2024-12-02 | 13G | Senti Biosciences, Inc. SNTI | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 301,500 5.914% | 301,500 (New Position) | Filing History |
| 2024-12-20 4:31 pm Sale | 2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 300,902 2.760% | -487,882 (-61.85%) | Filing History |
| 2024-12-04 4:31 pm Purchase | 2024-11-27 | 13G | InspireMD, Inc. NSPR | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1,411,636 5.220% | 1,411,636 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Surrozen, Inc. SRZN | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 176,970 5.280% | 176,970 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 788,784 7.760% | 576,608 (+271.76%) | Filing History |
| 2024-02-02 8:32 pm Purchase | 2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 212,175 6.100% | 212,175 (New Position) | Filing History |